Pinocembrin Suppresses HO-Induced Mitochondrial Dysfunction by a Mechanism Dependent on the Nrf2/HO-1 Axis in SH-SY5Y Cells
Overview
Neurology
Authors
Affiliations
Mitochondria are susceptible to redox impairment, which has been associated with neurodegeneration. These organelles are both a source and target of reactive species. In that context, there is increasing interest in finding natural compounds that modulate mitochondrial function and mitochondria-related signaling in order to prevent or to treat diseases involving mitochondrial impairment. Herein, we investigated whether and how pinocembrin (PB) would prevent mitochondrial dysfunction elicited by the exposure of human neuroblastoma SH-SY5Y cells to hydrogen peroxide (HO). PB (25 μM) was administrated for 4 h before HO treatment (300 μM for 24 h). PB prevented HO-induced loss of cell viability mitochondrial depolarization in SH-SY5Y cells. PB also attenuated redox impairment in mitochondrial membranes. The production of superoxide anion radical (O) and nitric oxide (NO) was alleviated by PB in cells exposed to HO. PB suppressed the HO-induced inhibition of the tricarboxylic acid (TCA) cycle enzymes aconitase, α-ketoglutarate dehydrogenase, and succinate dehydrogenase. Furthermore, PB induced anti-inflammatory effects by abolishing the HO-dependent activation of the nuclear factor-κB (NF-κB) and upregulation of interleukin-1β (IL-1β) and tumor necrosis factor-α (TNF-α). The PB-induced antioxidant and anti-inflammatory effects are dependent on the heme oxygenate-1 (HO-1) enzyme and on the activation of the transcription factor nuclear factor erythroid 2-related factor 2 (Nrf2), since HO-1 inhibition (with 0.5 μM ZnPP IX) or Nrf2 silencing (with small interfering RNA (siRNA)) abolished the effects of PB. Overall, PB afforded cytoprotection by the Nrf2/HO-1 axis in HO-treated SH-SY5Y cells.
Piezo1 promotes intervertebral disc degeneration through the Ca/F-actin/Yap signaling axis.
Peng F, Sun M, Jing X, Chen F, Cao T, Li Z Mol Med. 2025; 31(1):90.
PMID: 40057686 PMC: 11889814. DOI: 10.1186/s10020-025-01147-z.
Feng L, Wu Y, Wang J, Han Y, Huang J, Xu H Foods. 2023; 12(7).
PMID: 37048311 PMC: 10094291. DOI: 10.3390/foods12071490.
Wang T, Tian H, Pan T, Yao S, Yu H, Wu Y Sci Rep. 2022; 12(1):13885.
PMID: 35974041 PMC: 9381505. DOI: 10.1038/s41598-022-18297-3.
Liu Y, Zhao Y, Li K, Miao S, Xu Y, Zhao J Mol Biol Rep. 2022; 49(2):1045-1056.
PMID: 34981336 DOI: 10.1007/s11033-021-06925-6.
Chen W, Ye Y, Wu Z, Lin J, Wang Y, Ding Q Oxid Med Cell Longev. 2021; 2021:4053276.
PMID: 34840667 PMC: 8612781. DOI: 10.1155/2021/4053276.